Verastem Oncology (VSTM) Fails to deliver data

Key failure to deliver metrics for Verastem Oncology :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: NZ$0.56 M
• Last 3 months FTD volume: NZ$3.92 M
• Last 12 months FTD volume: NZ$20.4 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Verastem Oncology (VSTM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Verastem Oncology (VSTM) - since 2023

Verastem Oncology (VSTM) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$56.21 M	NZ$0.12 B	🇺🇸 USA
LabCorp LH	NZ$15.8 M	NZ$33.86 M	🇺🇸 USA
GSK plc GSK	NZ$48.95 M	NZ$0.36 B	🇬🇧 UK
Curis CRIS	NZ$0.23 M	NZ$1.17 M	🇺🇸 USA